Transplant cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy18

Transplants Antilymphocyte Serum Hematopoietic Stem Cells T-Lymphocytes Allografts Bone Marrow Cells Stem Cells Fetal Blood Liver Cells, Cultured Bone Marrow Kidney Mesenchymal Stromal Cells Blood Cells Spermatogonia Fetal Stem Cells CD8-Positive T-Lymphocytes Killer Cells, Natural

Organisms11

Transplantation Chimera Cytomegalovirus Mice, Inbred C57BL Rats, Inbred Lew BK Virus Mice, Inbred BALB C Chimera Herpesvirus 6, Human Mice, SCID Radiation Chimera Rats, Nude

Diseases55

Graft vs Host Disease Hematologic Neoplasms Recurrence Multiple Myeloma Postoperative Complications Leukemia Cytomegalovirus Infections Liver Failure Leukemia, Myeloid, Acute Hepatic Veno-Occlusive Disease Acute Disease Hematologic Diseases Cadaver Lymphoma, Non-Hodgkin Myelodysplastic Syndromes Anemia, Aplastic Precursor Cell Lymphoblastic Leukemia-Lymphoma Bronchiolitis Obliterans Infection Kidney Failure, Chronic Liver Diseases Leukemia, Myelogenous, Chronic, BCR-ABL Positive Lymphoproliferative Disorders Opportunistic Infections Hodgkin Disease Blood Group Incompatibility Severe Combined Immunodeficiency Neoplasm, Residual Mycoses Lymphoma Chronic Disease Leukemia, Myeloid Disease Models, Animal End Stage Liver Disease Aspergillosis Kidney Diseases Stomatitis Primary Graft Dysfunction Brain Death Epstein-Barr Virus Infections Neoplasms Amyloidosis Liver Failure, Acute Liver Cirrhosis Roseolovirus Infections Polyomavirus Infections Disease Progression Primary Myelofibrosis Immunologic Deficiency Syndromes Neoplasm Recurrence, Local Neutropenia Neoplasms, Second Primary Lymphoma, Follicular Renal Insufficiency Biliary Atresia

Chemicals and Drugs39

Immunosuppressive Agents Myeloablative Agonists Busulfan Cyclosporine Tacrolimus Melphalan HLA Antigens Vidarabine Antilymphocyte Serum Cyclophosphamide Mycophenolic Acid Antigens, CD34 Granulocyte Colony-Stimulating Factor Cytarabine Carmustine Etoposide Minor Histocompatibility Antigens Ganciclovir Isoantibodies Prednisone ABO Blood-Group System Thiotepa Antibodies, Monoclonal Antineoplastic Agents Antiviral Agents Vincristine Antineoplastic Agents, Alkylating Biological Markers Antibodies, Monoclonal, Murine-Derived Antibodies, Neoplasm Creatinine Isoantigens Sirolimus Antigens, CD Cyclosporins Methylprednisolone Podophyllotoxin Antifungal Agents Dexamethasone

Analytical, Diagnostic and Therapeutic Techniques and Equipment99

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Transplantation, Autologous Kidney Transplantation Liver Transplantation Transplantation Conditioning Bone Marrow Transplantation Peripheral Blood Stem Cell Transplantation Heart Transplantation Cell Transplantation Lung Transplantation Treatment Outcome Transplantation Cord Blood Stem Cell Transplantation Histocompatibility Testing Retrospective Studies Islets of Langerhans Transplantation Organ Transplantation Whole-Body Irradiation Immunosuppression Transplantation, Isogeneic Mesenchymal Stem Cell Transplantation Pancreas Transplantation Survival Analysis Survival Rate Combined Modality Therapy Follow-Up Studies Fetal Tissue Transplantation Remission Induction Heart-Lung Transplantation Transplantation, Heterotopic Disease-Free Survival Risk Factors Antineoplastic Combined Chemotherapy Protocols Hematopoietic Stem Cell Mobilization Salvage Therapy Brain Tissue Transplantation Lymphocyte Transfusion Prognosis Transplantation, Heterologous Lymphocyte Depletion Donor Selection Skin Transplantation Prospective Studies Tissue Transplantation Corneal Transplantation Fatal Outcome Incidence Facial Transplantation Biopsy Leukapheresis Bone Marrow Purging Cohort Studies Patient Selection Multivariate Analysis Kaplan-Meier Estimate Disease Models, Animal Flow Cytometry Postoperative Period Tissue and Organ Harvesting Feasibility Studies Actuarial Analysis Leukocyte Transfusion Models, Animal Polymerase Chain Reaction Registries Organ Preservation Lymphocyte Count Risk Assessment Proportional Hazards Models Cell Separation Cell- and Tissue-Based Therapy Drug Therapy, Combination Neoplasm Transplantation Hand Transplantation Blood Component Removal Platelet Transfusion Severity of Illness Index Pilot Projects Treatment Failure Immunophenotyping Blood Grouping and Crossmatching Life Tables Reoperation Platelet Count Postoperative Care Cryopreservation Predictive Value of Tests Cold Ischemia Cell Culture Techniques Clinical Trials as Topic Immunohistochemistry Leukocyte Count Cell Count Blood Transfusion Graft Enhancement, Immunologic Blood Cell Count Immunotherapy, Adoptive

Psychiatry and Psychology2

Siblings Nuclear Family

Phenomena and Processes25

Graft Survival Graft Rejection Transplantation Immunology Histocompatibility Time Factors Transplantation Tolerance Graft vs Leukemia Effect Graft vs Tumor Effect Chimerism Immunocompromised Host Hematopoiesis Virus Activation Cell Differentiation Regeneration Lymphocyte Count Recovery of Function Immune Tolerance Graft vs Host Reaction Host vs Graft Reaction Platelet Count Radiation Chimera Cell Survival Leukocyte Count Cell Count Blood Cell Count

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Siblings Nuclear Family

Information Science5

Survival Rate Fatal Outcome Incidence Registries Life Tables

Named Groups6

Tissue Donors Living Donors Siblings Unrelated Donors Survivors Blood Donors

Health Care32

Treatment Outcome Retrospective Studies Tissue and Organ Procurement Survival Analysis Survival Rate Follow-Up Studies Disease-Free Survival Waiting Lists Risk Factors Donor Selection Prospective Studies Fatal Outcome Incidence Directed Tissue Donation Cohort Studies Patient Selection Multivariate Analysis Kaplan-Meier Estimate Postoperative Period Feasibility Studies Actuarial Analysis Age Factors Registries Risk Assessment Proportional Hazards Models Severity of Illness Index Pilot Projects Treatment Failure Life Tables Postoperative Care Predictive Value of Tests Clinical Trials as Topic

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Transplantation, Autologous Kidney Transplantation Liver Transplantation Transplantation Conditioning Bone Marrow Transplantation Graft vs Host Disease Peripheral Blood Stem Cell Transplantation Graft Survival Heart Transplantation Cell Transplantation Tissue Donors Lung Transplantation Graft Rejection Immunosuppressive Agents Hematologic Neoplasms Treatment Outcome Transplantation Chimera Transplantation Cord Blood Stem Cell Transplantation Transplantation Immunology Histocompatibility Testing Retrospective Studies Islets of Langerhans Transplantation Transplants Organ Transplantation Myeloablative Agonists Recurrence Whole-Body Irradiation Living Donors Histocompatibility Time Factors Immunosuppression Busulfan Transplantation, Isogeneic Mesenchymal Stem Cell Transplantation Tissue and Organ Procurement Pancreas Transplantation Cyclosporine Survival Analysis Survival Rate Combined Modality Therapy Follow-Up Studies Fetal Tissue Transplantation Multiple Myeloma Tacrolimus Postoperative Complications Transplantation Tolerance Leukemia Remission Induction Melphalan Heart-Lung Transplantation Transplantation, Heterotopic Cytomegalovirus Infections HLA Antigens Graft vs Leukemia Effect Liver Failure Disease-Free Survival Vidarabine Waiting Lists Antilymphocyte Serum Cyclophosphamide Graft vs Tumor Effect Chimerism Leukemia, Myeloid, Acute Hepatic Veno-Occlusive Disease Risk Factors Siblings Antineoplastic Combined Chemotherapy Protocols Hematopoietic Stem Cell Mobilization Acute Disease Mycophenolic Acid Salvage Therapy Brain Tissue Transplantation Hematologic Diseases Unrelated Donors Lymphocyte Transfusion Immunocompromised Host Prognosis Cadaver Lymphoma, Non-Hodgkin Myelodysplastic Syndromes Anemia, Aplastic Transplantation, Heterologous Antigens, CD34 Precursor Cell Lymphoblastic Leukemia-Lymphoma Lymphocyte Depletion Donor Selection Bronchiolitis Obliterans Skin Transplantation Prospective Studies Infection Hematopoietic Stem Cells Tissue Transplantation Kidney Failure, Chronic Liver Diseases Leukemia, Myelogenous, Chronic, BCR-ABL Positive Lymphoproliferative Disorders

No FAQ available that match "transplant cell transplantation"